TuBerculosis Vaccine Initiative
Search

Category: News

Announcement TBVI Award 2025

Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Awards. Promising scientists are given the opportunity to give a 15-minute presentation (incl. discussion) about their work during the annual TBVI symposium where researchers, policy […]

TBVI and EVI team up with VAC4EU

TBVI and EVI announce a new partnership with Vaccine Monitoring Collaboration for Europe (VAC4EU). VAC4EU is a pan-European research network for post-authorisation vaccine safety and benefit monitoring, specialised in the collaborative generation of real-world evidence on coverage, safety, and efficacy of vaccines in Europe. TBVI and EVI are both European non-profit Product Development Partnerships (PDPs) […]

Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC

Biofabri and TBVI have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of […]

Vacancy at TBVI for a Scientific Project Manager

Image with text "We're hiring. Designed by Freepik."

TBVI has an exciting career opportunity for a motivated individual to join the organisation as Scientific Project Manager (full-time or part-time). You will join a small, enthusiastic team, dedicated to TBVI’s goals to relieve the burden of TB and eliminate tuberculosis around the world. Applications with the requested information should be submitted in English and […]

7th Global Forum on TB Vaccines – Participant support

Graphic with multi-colored frame and white background reading "Participant support available! Application deadline: 30 June 2024. Limited travel and registration support available for students, post-docs, early career researchers, advocates, members of affected communities, and participants from low- and middle-income countries. Apply at bit.ly/7GFTBVpartsup.”

As we believe that no one should be left out of the conversation, we offer travel and registration support (participant support) for participants planning to attend the 7th Global Forum on TB Vaccines. Support is available for students, post-docs, early career researchers, advocates, members of affected communities, and participants from LMICs. For more information, please […]

University of Oxford (UOXF) starts aligned clinical study – first participant enrolled

TBVAC-HORIZON - Univ. Oxford starts aligned clinical study

TBVAC-HORIZON has met an important milestone: On 3 April 2024, the first participant in the UOXF “TB46” study was enrolled. Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day. Prevention of TB infection by novel vaccines would provide the most cost-effective approach to achieve the goals of […]

7th Global Forum on TB vaccines – Call for abstracts

The Global Forum on TB Vaccines will take place from 8-10 October 2024 and will be hosted in Rio de Janeiro, Brazil. The Call for Abstracts for the 7th Global Forum on TB Vaccines is now available. Researchers, product developers, advocates, community representatives, and others engaged in new TB vaccines are encouraged to submit. Submissions […]

World Tuberculosis Day 2024 – We can End TB!

World Tuberculosis Day serves as a poignant reminder to raise awareness about tuberculosis (TB). Despite the efforts and promising developments in the fight against this disease, TB remains an endemic that leads to 1.3 million deaths each year. 24 March 2024 Innovations in medical science and public health strategies have provided powerful tools in the […]